Metraipolis › archive › dc_1eb39136304f

Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label,… — Europe PMC PMID:42183251

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42183251
DOI
10.3389/fimmu.2026.1770662
License (as archived)
solo-consultazione
Archived
2026-11-02T16:10:53.094Z
SHA-256 of the archived text
9c227b6691cbfb8fe6ed0f9ad556e166339f3a762bf91d60f4d207651e2bff84
Stable URL of this page
https://metraipolis.com/documento/dc_1eb39136304f

How to cite

Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label,… — Europe PMC PMID:42183251 — Europe PMC (en), https://europepmc.org/article/MED/42183251 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1eb39136304f (Metraipolis archive dc_1eb39136304f, sha256 9c227b6691cbfb8fe6ed0f9ad556e166339f3a762bf91d60f4d207651e2bff84)
BibTeX
@misc{dc1eb39136304f,
  title = {Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label,… — Europe PMC PMID:42183251},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42183251},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1eb39136304f; sha256 9c227b6691cbfb8fe6ed0f9ad556e166339f3a762bf91d60f4d207651e2bff84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42183251. Agents can read the archived copy with the MCP tool read_document.